{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:49:21Z","timestamp":1786499361861,"version":"build-2736575974"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,4,12]],"date-time":"2011-04-12T00:00:00Z","timestamp":1302566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s10096-011-1236-8","type":"journal-article","created":{"date-parts":[[2011,10,11]],"date-time":"2011-10-11T14:50:40Z","timestamp":1318344640000},"page":"1417-1424","source":"Crossref","is-referenced-by-count":51,"title":["Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia"],"prefix":"10.1007","volume":"30","author":[{"given":"T.","family":"M\u00f6lk\u00e4nen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ruotsalainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. W.","family":"Thorball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,12]]},"reference":[{"issue":"1","key":"1236_CR1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/647704","volume":"19","author":"LO Conterno","year":"1998","unstructured":"Conterno LO, Wey SB, Castelo A (1998) Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19(1):32\u201337","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"1236_CR2","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1469-0691.2006.01589.x","volume":"13","author":"T Benfield","year":"2007","unstructured":"Benfield T, Espersen F, Frimodt-M\u00f8ller N et al (2007) Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000. Clin Microbiol Infect 13(3):257\u2013263","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1236_CR3","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1086\/317421","volume":"31","author":"JM Mylotte","year":"2000","unstructured":"Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31(5):1170\u20131174","journal-title":"Clin Infect Dis"},{"issue":"17","key":"1236_CR4","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1001\/archinte.163.17.2066","volume":"163","author":"VG Fowler Jr","year":"2003","unstructured":"Fowler VG Jr, Olsen MK, Corey GR et al (2003) Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch Intern Med 163(17):2066\u20132072","journal-title":"Arch Intern Med"},{"issue":"3","key":"1236_CR5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s10096-003-1083-3","volume":"23","author":"G F\u00e4tkenheuer","year":"2004","unstructured":"F\u00e4tkenheuer G, Preuss M, Salzberger B et al (2004) Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis 23(3):157\u2013162","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"1236_CR6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1365-2796.2005.01598.x","volume":"259","author":"E Ruotsalainen","year":"2006","unstructured":"Ruotsalainen E, J\u00e4rvinen A, Koivula I et al (2006) Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients. J Intern Med 259(2):179\u2013190","journal-title":"J Intern Med"},{"issue":"1","key":"1236_CR7","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/cc8872","volume":"14","author":"C Pierrakos","year":"2010","unstructured":"Pierrakos C, Vincent JL (2010) Sepsis biomarkers: a review. Crit Care 14(1):R15","journal-title":"Crit Care"},{"issue":"3","key":"1236_CR8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1378\/chest.120.3.915","volume":"120","author":"SB Yan","year":"2001","unstructured":"Yan SB, Helterbrand JD, Hartman DL, Wright TJ, Bernard GR (2001) Low levels of protein C are associated with poor outcome in severe sepsis. Chest 120(3):915\u2013922","journal-title":"Chest"},{"key":"1236_CR9","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1100\/tsw.2010.181","volume":"10","author":"M Hatzistilianou","year":"2010","unstructured":"Hatzistilianou M (2010) Diagnostic and prognostic role of procalcitonin in infections. ScientificWorldJournal 10:1941\u20131946","journal-title":"ScientificWorldJournal"},{"issue":"47","key":"1236_CR10","doi-asserted-by":"crossref","first-page":"48487","DOI":"10.1074\/jbc.R400025200","volume":"279","author":"S Black","year":"2004","unstructured":"Black S, Kushner I, Samols D (2004) C-reactive protein. J Biol Chem 279(47):48487\u201348490","journal-title":"J Biol Chem"},{"issue":"3","key":"1236_CR11","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00134-002-1209-6","volume":"28","author":"P P\u00f3voa","year":"2002","unstructured":"P\u00f3voa P (2002) C-reactive protein: a valuable marker of sepsis. Intensive Care Med 28(3):235\u2013243","journal-title":"Intensive Care Med"},{"issue":"2","key":"1236_CR12","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/cc4892","volume":"10","author":"P P\u00f3voa","year":"2006","unstructured":"P\u00f3voa P, Coelho L, Almeida E et al (2006) Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. Crit Care 10(2):R63","journal-title":"Crit Care"},{"issue":"6","key":"1236_CR13","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1378\/chest.123.6.2043","volume":"123","author":"SM Lobo","year":"2003","unstructured":"Lobo SM, Lobo FR, Bota DP et al (2003) C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123(6):2043\u20132049","journal-title":"Chest"},{"issue":"5","key":"1236_CR14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s00134-009-1402-y","volume":"35","author":"J Silvestre","year":"2009","unstructured":"Silvestre J, P\u00f3voa P, Coelho L et al (2009) Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35(5):909\u2013913","journal-title":"Intensive Care Med"},{"issue":"12","key":"1236_CR15","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrm977","volume":"3","author":"F Blasi","year":"2002","unstructured":"Blasi F, Carmeliet P (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3(12):932\u2013943","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"1236_CR16","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.150398","volume":"15","author":"T Plesner","year":"1997","unstructured":"Plesner T, Behrendt N, Ploug M (1997) Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 15(6):398\u2013408","journal-title":"Stem Cells"},{"issue":"5761","key":"1236_CR17","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1121143","volume":"311","author":"Q Huai","year":"2006","unstructured":"Huai Q, Mazar AP, Kuo A et al (2006) Structure of human urokinase plasminogen activator in complex with its receptor. Science 311(5761):656\u2013659","journal-title":"Science"},{"issue":"2","key":"1236_CR18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/(SICI)1097-0215(19980717)77:2<236::AID-IJC12>3.0.CO;2-9","volume":"77","author":"H Witte De","year":"1998","unstructured":"De Witte H, Sweep F, Br\u00fcnner N et al (1998) Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay. Int J Cancer 77(2):236\u2013242","journal-title":"Int J Cancer"},{"issue":"6","key":"1236_CR19","first-page":"717","volume":"79","author":"CF Sier","year":"1999","unstructured":"Sier CF, Sidenius N, Mariani A et al (1999) Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest 79(6):717\u2013722","journal-title":"Lab Invest"},{"issue":"1\u20132","key":"1236_CR20","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S0165-5728(02)00186-8","volume":"129","author":"JC Garcia-Monco","year":"2002","unstructured":"Garcia-Monco JC, Coleman JL, Benach JL (2002) Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases. J Neuroimmunol 129(1\u20132):216\u2013223","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1236_CR21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/01.qai.0000157950.02076.a6","volume":"39","author":"SR Ostrowski","year":"2005","unstructured":"Ostrowski SR, Piironen T, H\u00f8yer-Hansen G et al (2005) High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients. J Acquir Immune Defic Syndr 39(1):23\u201331","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"1236_CR22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.clim.2009.01.007","volume":"131","author":"B Fevang","year":"2009","unstructured":"Fevang B, Eugen-Olsen J, Yndestad A et al (2009) Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency. Clin Immunol 131(3):438\u2013446","journal-title":"Clin Immunol"},{"issue":"13","key":"1236_CR23","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","volume":"96","author":"N Sidenius","year":"2000","unstructured":"Sidenius N, Sier CF, Ullum H et al (2000) Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96(13):4091\u20134095","journal-title":"Blood"},{"issue":"8","key":"1236_CR24","first-page":"686","volume":"6","author":"J Eugen-Olsen","year":"2002","unstructured":"Eugen-Olsen J, Gustafson P, Sidenius N et al (2002) The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int J Tuberc Lung Dis 6(8):686\u2013692","journal-title":"Int J Tuberc Lung Dis"},{"issue":"6","key":"1236_CR25","first-page":"717","volume":"79","author":"CF Sier","year":"1999","unstructured":"Sier CF, Sidenius N, Mariani A et al (1999) Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest 79(6):717\u2013722","journal-title":"Lab Invest"},{"issue":"9","key":"1236_CR26","first-page":"1843","volume":"58","author":"CF Sier","year":"1998","unstructured":"Sier CF, Stephens R, Bizik J et al (1998) The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients. Cancer Res 58(9):1843\u20131849","journal-title":"Cancer Res"},{"issue":"3","key":"1236_CR27","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1155\/2009\/504294","volume":"27","author":"M Thun\u00f8","year":"2009","unstructured":"Thun\u00f8 M, Macho B, Eugen-Olsen J (2009) suPAR: the molecular crystal ball. Dis Markers 27(3):157\u2013172","journal-title":"Dis Markers"},{"issue":"6","key":"1236_CR28","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1046\/j.1523-1755.2001.00719.x","volume":"59","author":"S Florquin","year":"2001","unstructured":"Florquin S, van den Berg JG, Olszyna DP et al (2001) Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia. Kidney Int 59(6):2054\u20132061","journal-title":"Kidney Int"},{"issue":"5","key":"1236_CR29","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1469-0691.2004.00850.x","volume":"10","author":"P Wittenhagen","year":"2004","unstructured":"Wittenhagen P, Kronborg G, Weis N et al (2004) The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality. Clin Microbiol Infect 10(5):409\u2013415","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"1236_CR30","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.0141-9838.2004.00695.x","volume":"26","author":"M Perch","year":"2004","unstructured":"Perch M, Kofoed P, Fischer TK et al (2004) Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection. Parasite Immunol 26(5):207\u2013211","journal-title":"Parasite Immunol"},{"issue":"2","key":"1236_CR31","doi-asserted-by":"crossref","first-page":"R38","DOI":"10.1186\/cc5723","volume":"11","author":"K Kofoed","year":"2007","unstructured":"Kofoed K, Andersen O, Kronborg G et al (2007) Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 11(2):R38","journal-title":"Crit Care"},{"key":"1236_CR32","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/archinte.1962.03620230109016","volume":"110","author":"GG Jackson","year":"1962","unstructured":"Jackson GG, Arana-Sialer JA, Andersen BR, Grieble HG, McCabe WR (1962) Profiles of pyelonephritis. Arch Intern Med 110:63\u201375","journal-title":"Arch Intern Med"},{"issue":"9","key":"1236_CR33","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1086\/320001","volume":"32","author":"LA Mermel","year":"2001","unstructured":"Mermel LA, Farr BM, Sherertz RJ et al (2001) Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis 32(9):1249\u20131272","journal-title":"Clin Infect Dis"},{"key":"1236_CR34","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-2334-6-137","volume":"6","author":"E Ruotsalainen","year":"2006","unstructured":"Ruotsalainen E, Sammalkorpi K, Laine J et al (2006) Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients. BMC Infect Dis 6:137","journal-title":"BMC Infect Dis"},{"issue":"10","key":"1236_CR35","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1097\/01.CCM.0000239120.32490.AB","volume":"34","author":"HJ M\u00f8ller","year":"2006","unstructured":"M\u00f8ller HJ, Moestrup SK, Weis N et al (2006) Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163. Crit Care Med 34(10):2561\u20132566","journal-title":"Crit Care Med"},{"key":"1236_CR36","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1471-2334-7-134","volume":"7","author":"UV Schneider","year":"2007","unstructured":"Schneider UV, Nielsen RL, Pedersen C et al (2007) The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms. BMC Infect Dis 7:134","journal-title":"BMC Infect Dis"},{"issue":"9","key":"1236_CR37","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/j.1365-3156.2009.02328.x","volume":"14","author":"P Rabna","year":"2009","unstructured":"Rabna P, Andersen A, Wejse C et al (2009) High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test. Trop Med Int Health 14(9):986\u2013994","journal-title":"Trop Med Int Health"},{"issue":"6","key":"1236_CR38","doi-asserted-by":"crossref","first-page":"805","DOI":"10.3109\/0284186X.2010.491086","volume":"49","author":"AF Lomholt","year":"2010","unstructured":"Lomholt AF, Christensen IJ, H\u00f8yer-Hansen G et al (2010) Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients. Acta Oncol 49(6):805\u2013811","journal-title":"Acta Oncol"},{"issue":"2","key":"1236_CR39","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","volume":"80","author":"O Andersen","year":"2008","unstructured":"Andersen O, Eugen-Olsen J, Kofoed K, Iversen J, Haugaard SB (2008) Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. J Med Virol 80(2):209\u2013216","journal-title":"J Med Virol"},{"issue":"10","key":"1236_CR40","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1093\/clinchem\/43.10.1868","volume":"43","author":"RW Stephens","year":"1997","unstructured":"Stephens RW, Pedersen AN, Nielsen HJ et al (1997) ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients. Clin Chem 43(10):1868\u20131876","journal-title":"Clin Chem"}],"container-title":["European Journal of Clinical Microbiology &amp; Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1236-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10096-011-1236-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-011-1236-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T21:11:09Z","timestamp":1593119469000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10096-011-1236-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,12]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["1236"],"URL":"https:\/\/doi.org\/10.1007\/s10096-011-1236-8","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,12]]}}}